Depressed Jane

Let Me Tell You More About My Depressed, Miserable Existence

Archive for March, 2009

There is no evidence that desvenlafaxine (Pristiq) is more effective, safer or better tolerated than its parent drug, venlafaxine, or other antidepressants, NPS advises in the latest edition of NPS RADAR. Desvenlafaxine was recently listed on the PBS for major depressive disorder. It is the active metabolite of venlafaxine but there is no evidence that it has any particular advantage over venlafaxine.

Popularity: 1% [?]

A collaborative study led by researchers at the Montreal Neurological Institute (MNI), McGill University has demonstrated a positive link between cognitive ability and cortical thickness in the brains of healthy 6 to 18 year olds. The correlation is evident in regions that integrate information from different parts of the brain.

Popularity: 1% [?]

US scientists conducting the largest ever imaging study of depression found that a thinning of the brain’s cortex in the right hemisphere appeared to be linked to inherited or the familial form of depression.

Popularity: unranked [?]

Largest-ever imaging study of depression implicates structural changes in brain’s cortex Findings from one of the largest-ever imaging studies of depression indicate that a structural difference in the brain – a thinning of the right hemisphere – appears to be linked to a higher risk for depression, according to new research at Columbia University Medical Center and the New York State Psychiatric Institute. The research was led by Myrna Weissman, Ph.D.

Popularity: unranked [?]

The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax(R) (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company (NYSE: LLY) announced. Symbyax is now the first drug approved by the FDA for the acute treatment of treatment-resistant depression (TRD). “Living with major depressive disorder is difficult and distressing for anyone, but even more so for patients whose symptoms continue despite treatment,” said Lilly Medical Director Dr.

Popularity: 1% [?]

Forest Laboratories, Inc. (NYSE: FRX) announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for Lexapro (escitalopram oxalate) for the acute and maintenance treatment of Major Depressive Disorder (MDD) in adolescents, 12 – 17 years of age. Lexapro is only the second antidepressant to be approved for the treatment of MDD in adolescents, a medical condition that affects approximately 2 million adolescents in the U.S.

Popularity: unranked [?]

Creating a family life incorporating the care needs of a child dependent on technology is a daunting task. Much of this task seems to fall upon mothers to help everyone in the family adjust. However, mothers often need help of their own to cope with the challenges of raising these children, a research study from Case Western Reserve University has found. “The family takes its cues from me,” one mother told Valerie Toly, PhD, R.N., C.P.N.P.

Popularity: unranked [?]

Creating a family life incorporating the care needs of a child dependent on technology is a daunting task. Much of this task seems to fall upon mothers to help everyone in the family adjust. However, mothers often need help of their own to cope with the challenges of raising these children, a research study from Case Western Reserve University has found. “The family takes its cues from me,” one mother told Valerie Toly, PhD, R.N., C.P.N.P.

Popularity: 1% [?]

Less than an hour of daily exercise reduces depressive symptoms and improves self esteem in overweight children, Medical College of Georgia researchers say. The study included 207 overweight, typically sedentary children ages 7-11 randomly assigned to either continue their sedentary lifestyle or exercise for 20 or 40 minutes every day after school for an average of 13 weeks.

Popularity: 1% [?]

With the nation’s economic crisis contributing to greater workplace stress, providing effective mental health care for employees may be more important than ever. Unfortunately, the approach most companies take in purchasing mental health care benefits is flawed and unlikely to produce the best outcomes for either their bottom line or their employees’ welfare, according to a Florida State University College of Medicine researcher.

Popularity: unranked [?]